Ms A complained about the provision of hormone medication to her daughter, Ms B, via the GP and the Local Gender Team within the Health Board’s area.
The Ombudsman found that the Health Board did not currently have a consistent pathway for gender patients to be prescribed specialist hormone medication with appropriate monitoring and review. The Health Board was aware of the issues regarding this service. The Health Board agreed that, within six months, arrangements for the prescribing, monitoring and review of hormone treatment (for all gender service patients within the Health Board’s area) would be transferred to the Health Board’s Local Gender Team and provided via local sexual health clinics. In the interim, it would continue to provide Ms B with the required medication via her local sexual health clinic.
